Meta-analysis on the association between nonsteroidal anti-inflammatory drug use and lung cancer risk.

[1]  P. Rothwell,et al.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials , 2011, The Lancet.

[2]  T. le Chevalier.  Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going? , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  A. Tenesa,et al.  Effect of aspirin and NSAIDs on risk and survival from colorectal cancer , 2010, Gut.

[4]  Fan Wang,et al.  Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis , 2009, Breast Cancer Research and Treatment.

[5]  M. Thun,et al.  Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. , 2009, The Lancet. Oncology.

[6]  E. White,et al.  Association of Nonsteroidal Anti-Inflammatory Drugs with Lung Cancer: Results from a Large Cohort Study , 2009, Cancer Epidemiology Biomarkers & Prevention.

[7]  C. Abnet,et al.  Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis , 2009, British Journal of Cancer.

[8]  J. Hirsh,et al.  Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[9]  B. Strom,et al.  Lung cancer and regular use of aspirin and nonaspirin nonsteroidal anti‐inflammatory drugs , 2008, Pharmacoepidemiology and drug safety.

[10]  A. Schwartz,et al.  Regular Adult Aspirin Use Decreases the Risk of Non-Small Cell Lung Cancer among Women , 2008, Cancer Epidemiology Biomarkers & Prevention.

[11]  A. Tjønneland,et al.  Use of NSAIDs, smoking and lung cancer risk , 2007, British Journal of Cancer.

[12]  F. Speizer,et al.  Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency , 2007, British Journal of Cancer.

[13]  Randall Harris,et al.  Reduced Risk of Human Lung Cancer by Selective Cyclooxygenase 2 (Cox-2) Blockade: Results of a Case Control Study , 2007, International journal of biological sciences.

[14]  M. Thun,et al.  A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. , 2007, Journal of the National Cancer Institute.

[15]  S. Hernández-Díaz,et al.  Nonsteroidal anti‐inflammatory drugs and risk of lung cancer , 2007, International journal of cancer.

[16]  Y. Shyr,et al.  Nonsteroidal Anti-Inflammatory Drugs and Lung Cancer Risk: A Population-Based Case Control Study , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  A. Folsom,et al.  Association between Nonsteroidal Anti-inflammatory Drug Use and the Incidence of Lung Cancer in the Iowa Women's Health Study , 2006, Cancer Epidemiology Biomarkers & Prevention.

[18]  J. Manson,et al.  Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. , 2005, JAMA.

[19]  Deepak L. Bhatt,et al.  Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. , 2005, The American journal of cardiology.

[20]  S. Khuder,et al.  Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis. , 2005, Chest.

[21]  B. Graubard,et al.  Aspirin use and mortality from cancer in a prospective cohort study. , 2004, Anticancer research.

[22]  L. G. García Rodríguez,et al.  Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  R. López‐Ridaura,et al.  Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis , 2003, BMC Cancer.

[24]  E. Giovannucci,et al.  Aspirin use and lung cancer in men , 2003, British Journal of Cancer.

[25]  H T Sørensen,et al.  Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study , 2003, British Journal of Cancer.

[26]  A. Neugut,et al.  Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs , 2003, Cancer.

[27]  J. Olsen,et al.  A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin , 2003, British Journal of Cancer.

[28]  G. Bepler,et al.  Regular aspirin use and lung cancer risk , 2002, BMC Cancer.

[29]  R. Shore,et al.  Aspirin and lung cancer in women , 2002, British Journal of Cancer.

[30]  Randall Harris,et al.  Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers. , 2002, Oncology reports.

[31]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[32]  M. Thun,et al.  Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. , 2002, Journal of the National Cancer Institute.

[33]  Alex J Sutton,et al.  Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. , 2002, International journal of epidemiology.

[34]  R. Lancashire,et al.  Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database , 2000, BMJ : British Medical Journal.

[35]  A. Ristimäki,et al.  Expression of cyclooxygenase-2 in human lung carcinoma. , 1998, Cancer research.

[36]  Y. Yatabe,et al.  Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. , 1998, Cancer research.

[37]  L. Rosenberg.  Nonsteroidal anti-inflammatory drugs and cancer. , 1995, Preventive medicine.

[38]  R. Everson,et al.  Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study , 1994, Epidemiology.

[39]  M. Thun,et al.  Aspirin use and risk of fatal cancer. , 1993, Cancer research.

[40]  A. Paganini-Hill,et al.  Aspirin use and chronic diseases: a cohort study of the elderly. , 1989, BMJ.

[41]  R. Doll,et al.  Randomised trial of prophylactic daily aspirin in British male doctors , 1988, British medical journal.

[42]  C. la Vecchia,et al.  Aspirin and cancer risk: a summary review to 2007. , 2009, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[43]  Christopher S. Elliott.  The Chemoprevention of Lung Cancer Using Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) , 2003 .